| Natalia B Russell, CRNA | |
|
94 Old Short Hills Rd, Livingston, NJ 07039-5672 | |
| (201) 893-9449 | |
| Not Available |
| Full Name | Natalia B Russell |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 94 Old Short Hills Rd, Livingston, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326712753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | 26NR17248500 (New Jersey) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ01215800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia Of New Jersey Llc | 5890867410 | 226 |
| Dayton Anesthesia And Pain Services Llc | 8022245372 | 195 |
News Archive
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, today announced that it has begun to immunize subjects in a Phase IIa clinical trial of the Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the safety and immunogenicity of the Multimeric-001 vaccine.
Zimbabwean health officials responding to typhoid outbreaks in the capital of Harare that have affected more than 2,000 people "have called on the local and central governments to overhaul water and sanitation systems" to stem the spread of the disease, VOA News reports.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
› Verified 1 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, today announced that it has begun to immunize subjects in a Phase IIa clinical trial of the Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the safety and immunogenicity of the Multimeric-001 vaccine.
Zimbabwean health officials responding to typhoid outbreaks in the capital of Harare that have affected more than 2,000 people "have called on the local and central governments to overhaul water and sanitation systems" to stem the spread of the disease, VOA News reports.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalia B Russell, CRNA 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (201) 893-9449 | Natalia B Russell, CRNA 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (201) 893-9449 |
News Archive
The National Comprehensive Cancer Network Oncology Research Program is collaborating with Pfizer Independent Grants for Learning & Change (IGLC) to establish a peer-reviewed grant program to elicit proposals focused on health care provider performance and/or health care quality improvement and education projects.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of global efforts towards the development of a Universal Influenza Vaccine, today announced that it has begun to immunize subjects in a Phase IIa clinical trial of the Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the safety and immunogenicity of the Multimeric-001 vaccine.
Zimbabwean health officials responding to typhoid outbreaks in the capital of Harare that have affected more than 2,000 people "have called on the local and central governments to overhaul water and sanitation systems" to stem the spread of the disease, VOA News reports.
Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.
› Verified 1 days ago
Christina M Starker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000 Fax: 973-660-9779 | |
Boris G Kouanang, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd Ste 1, Livingston, NJ 07039 Phone: 973-322-5000 | |
John Tomasello, CRNA, APN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd Ste 1, Livingston, NJ 07039 Phone: 973-322-5000 | |
Ms. Randi Terry Davis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 S Orange Ave, Livingston, NJ 07039 Phone: 973-577-4056 | |
Dr. Stephen Patrick Pilot, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000 | |
Cori Kutzin, APN, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000 | |
Mr. Mcalistair James, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000 |